Fig. 4From: Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an exampleTumor uptake of 89Zr-trastuzumab as a function of HER2 concentration. Total administered mass dose 50 mg. Vertical dashed lines indicate the boundaries between the IHC classesBack to article page